Lado Abeal Joaquin, Albero Gamboa Ramón, Araujo Vilar David, Barca Mallo Olga, Bernabeú Moron Ignacio, Calvo María Teresa, Castro Piedras Isabel, Martin Calamata Jesús, Palos Paz Fernando, Peinó Roberto, Peteiro Diego, Victoria Berta
UETeM, Departamento de Medicina, Facultad de Medicina, Universidad de Santiago de Compostela, Santiago de Compostela, La Coruña, España.
Med Clin (Barc). 2011 Nov 12;137(12):551-4. doi: 10.1016/j.medcli.2010.11.037. Epub 2011 Jun 23.
Resistance to thyroid hormone (RTH) is a syndrome mostly caused by mutations in thyroid hormone receptor beta gen (THRB). We present five families with RTH phenotype.
THRB gene sequencing. In vitro studies to evaluate the mutants response to thyroid hormones and their dominant negative effect. Mechanism of resistance in patients with RTH without THRB mutations quantifying expression of regulator of calcineurin 2 (ZAKI4) and Kruppel-like factor 9 (BTEB) genes in patients fibroblast cultures.
THRB mutations were found in three cases: R243Q, R320C, R429Q. Mutants showed a decreased response to T3. R243Q and R320C had a strong dominant negative effect. One subject without THRB mutation showed changes in ZAKI4 and BTEB expression similar to R320C and the other showed expression levels higher than normal controls.
Three cases of RTH were caused by THRB heterozygous mutations but in two cases mutations were not found. THRB mutation carriers and one of the patients without mutations share a similar mechanism of resistance and in the other subject RTH is TRβ independent.
甲状腺激素抵抗(RTH)是一种主要由甲状腺激素受体β基因(THRB)突变引起的综合征。我们报告了五个具有RTH表型的家系。
进行THRB基因测序。开展体外研究以评估突变体对甲状腺激素的反应及其显性负效应。对无THRB突变的RTH患者,通过定量其成纤维细胞培养物中钙调神经磷酸酶2调节因子(ZAKI4)和Kruppel样因子9(BTEB)基因的表达,研究其抵抗机制。
在三例患者中发现了THRB突变:R243Q、R320C、R429Q。突变体对T3的反应降低。R243Q和R320C具有较强的显性负效应。一名无THRB突变的受试者显示出与R320C相似的ZAKI4和BTEB表达变化,另一名受试者的表达水平高于正常对照。
三例RTH由THRB杂合突变引起,但两例未发现突变。THRB突变携带者和一名无突变患者具有相似的抵抗机制,而另一名受试者的RTH与TRβ无关。